Exploration of sodium homeostasis and pharmacokinetics in bile duct-ligated rats treated by anti-cirrhosis herbal formula plus spironolactone

Exploration of sodium homeostasis and pharmacokinetics in bile duct-ligated rats treated by anti-cirrhosis herbal formula plus spironolactone

Renal sodium retention is an essential indicator that is used for the prognosis of cirrhosis with ascites that requires diuretic treatment to restore sodium homeostasis. The diuretic effects of Yin-Chen-Hao-Tang (YCHT) alone or in combination with diuretics for sodium retention in patients with cirr...

Full description

Bibliographic Details
Main Authors:	Tun-Pin Hsueh, Tung-Hu Tsai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Pharmacology
Subjects:	Yin-Chen-Hao-Tang spironolactone cirrhosis ascites canrenone reninangiotensin–aldosterone system
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1092657/full

Similar Items

Preclinical Pharmacokinetics of Scoparone, Geniposide and Rhein in an Herbal Medicine Using a Validated LC-MS/MS Method
by: Tun-Pin Hsueh, et al.
Published: (2018-10-01)

Using Light Microscopy and Liquid Chromatography Tandem Mass Spectrometry for Qualitative and Quantitative Control of a Combined Three-Herb Formulation in Different Preparations
by: Tun-Pin Hsueh, et al.
Published: (2016-12-01)

Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone
by: Tun-Pin Hsueh, et al.
Published: (2020-08-01)

The Pharmacological Effects and Pharmacokinetics of Active Compounds of <i>Artemisia capillaris</i>
by: Tun-Pin Hsueh, et al.
Published: (2021-10-01)

Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation
by: Shin-Hun Juang, et al.
Published: (2020-12-01)

Yin-Chen-Hao Tang Attenuates Severe Acute Pancreatitis in Rat: An Experimental Verification of In silico Network Target Prediction
by: Hong Xiang, et al.
Published: (2016-10-01)

Corrigendum: Yin-Chen-Hao Tang Attenuates Severe Acute Pancreatitis in Rat: An Experimental Verification of In silico Network Target Prediction
by: Hong Xiang, et al.
Published: (2018-10-01)

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
by: Ha Yeon Kim, et al.
Published: (2014-12-01)

Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1‐7)/MAS receptor axes in human mesangial cells
by: Danielle Stoll, et al.
Published: (2019-06-01)

ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01)

Recent Studies and Progression of Yin Chen Hao (茵陳蒿 Yīn Chén Hāo), a Long-term Used Traditional Chinese Medicine
by: Hsin-Yi Hung, et al.
Published: (2013-01-01)

Serum Metabolomic Characterization of Liver Fibrosis in Rats and Anti-Fibrotic Effects of Yin-Chen-Hao-Tang
by: Hongyang Zhang, et al.
Published: (2016-01-01)

Spironolactone-Induced Agranulocytosis: A Case Report
by: Shu-Hwa Hsiao, et al.
Published: (2003-11-01)

Analysis of spironolactone polymorphs in active pharmaceutical ingredients and their effect on tablet dissolution profiles
by: Renata Cunha de Resende, et al.

Efficacy and safety of HCQ versus spironolactone in treatment of IgA nephropathy based on RAASi: a real-world study
by: QIN Jian, et al.
Published: (2022-07-01)

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
by: Marco Vicenzi, et al.
Published: (2020-09-01)

Clinical efficacy of potassium canreonate-canrenone in sinus rhythm restoration among patients with atrial fibrillation - a protocol of a pilot, randomized, double -blind, placebo-controlled study (CANREN-AF trial)
by: Rafał Dąbrowski, et al.
Published: (2020-05-01)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
by: Yaping Dong, et al.
Published: (2023-09-01)

Evaluation of Spironolactone in Combination with Furosemide in Cirrhotic Patients with Permagna (Large) Ascites
by: Tuty Mulyani, et al.
Published: (2017-11-01)

The paradox of spironolactone: A heart failure treatment with potentially harmful effects
by: Muhammad Roshan, et al.
Published: (2024-01-01)

The paradox of spironolactone: A heart failure treatment with potentially harmful effects
by: Muhammad Roshan, et al.
Published: (2024-01-01)

KHẢO SÁT NĂNG SUẤT SINH SẢN CỦA HEO NÁI LAI (LANDRACE x YORKSHIRE, YORKSHIRE x LANDRACE) VÀ SỰ SINH TRƯỞNG CỦA HEO CON ĐẾN 60 NGÀY TUỔI THUỘC HAI NHÓM GIỐNG DUROC x (LANDRACE x YORKSHIRE) VÀ DUROC x (YORKSHIRE x LANDRACE) Ở TRANG TRẠI
by: Lê Thị Mến
Published: (2015-12-01)

Possible role of Spironolactone in a sample of Iraqi patients with acute central serous chorioretinopathy
by: Marwa Majeed Hameed, et al.
Published: (2022-05-01)

Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
by: Catherine J. Leader, et al.
Published: (2020-05-01)

Activation of RAAS Signaling Contributes to Hypertension in Aged <i>Hyp</i> Mice
by: Nejla Latic, et al.
Published: (2022-07-01)

Effect of Spironolactone on COVID-19 in Patients With Underlying Liver Cirrhosis: A Nationwide Case-Control Study in South Korea
by: Dongsub Jeon, et al.
Published: (2021-02-01)

Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients
by: Fanfang Zeng, et al.
Published: (2019-06-01)

Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
by: Kapil G. Kapoor, et al.
Published: (2017-07-01)

Compatibility determination of potassium orotate with spironolactone by high-performance liquid chromatography
by: Ecaterina Mazur, et al.
Published: (2020-10-01)

Influence of Different Treatment Strategies on New‐Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort‐Based Study
by: Chien‐Ting Pan, et al.
Published: (2020-03-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
by: Alexandra Poinas, et al.
Published: (2020-06-01)

Efficacy of spironolactone in adult acne in polycystic ovary syndrome patients an original research
by: Neha Rani, et al.
Published: (2021-01-01)

Addition of spironolactone in patients with resistant hypertension: A meta-analysis of randomized controlled trials
by: Liping Liu, et al.
Published: (2017-04-01)

Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change
by: Sudeep R. Aryal, et al.
Published: (2021-09-01)

Improving the dissolution properties of spironolactone using liquisolid technique
by: Jafar Akbari, et al.
Published: (2015-09-01)

MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
by: V. N. Soboleva, et al.
Published: (2015-01-01)

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
by: Argen Mamazhakypov, et al.
Published: (2023-01-01)

Sodium renders endothelial cells sticky for red blood cells
by: Hans eOberleithner, et al.
Published: (2015-06-01)